Effect of side-chain structures on gene transfer efficiency of biodegradable cationic polyphosphoesters

被引:38
作者
Wang, J
Huang, SW
Zhang, PC
Mao, HQ
Leong, KW
机构
[1] Johns Hopkins Singapore, Tissue & Therapeut Engn Lab, Clin Res Ctr, Singapore 117597, Singapore
[2] Johns Hopkins Univ, Dept Biomed Engn, Sch Med, Baltimore, MD 21205 USA
关键词
non-viral gene delivery; sustained release; polymeric carrier; polyphosphoester;
D O I
10.1016/j.ijpharm.2003.07.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cationic polyphosphoesters (PPEs) with different side-chain charge groups were designed and synthesized as biodegradable gene carriers. Poly(N-methyl-2-aminoethyl propylene phosphate) (PPE-MEA), with a secondary amino group (-CH2CH2NHCH3) side chain released DNA in several hours at N/P (amino group of polymer to phosphate group of DNA) ratios from 0.5 to 5; whereas PPE-HA, bearing -CH2(CH2)(4)CH2NH2 groups in the side chain, did not release DNA at the same ratio range for 30 days. Hydrolytic degradation and DNA binding results suggested that side chain cleavage, besides the polymer degradation, was the predominant factor affected the DNA release and transfection efficiencies. The side chain of PPE-MEA was cleaved faster than that of PPE-HA, resulting poor cellular uptake and no transgene expression for PPE-MEA/DNA complexes in COS-7 cells at charge ratios from 4 to 12. In contrast, PPE-HA/DNA complexes were stable enough to be internalized by cells and effected gene transfection (3400 folds higher than background at a charge ratio of 12). Interestingly, gene expression levels mediated by PPE-MEA and PPE-HA in mouse muscle following intramuscular injection of complexes showed a reversed order: PPE-MEA/DNA complexes mediated a 1.5-2-fold higher luciferase expression in mouse muscle as compared with naked DNA injection, while PPE-HA/DNA complexes induced delayed and lowered luciferase expression than naked DNA. These results suggested that the side chain structure is a crucial factor determining the mechanism and kinetics of hydrolytic degradation of PPE carriers, which in turn influenced the kinetics of DNA release from PPE/DNA complexes and their transfection abilities in vitro and in vivo. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:75 / 84
页数:10
相关论文
共 27 条
  • [1] HYDROLYSIS OF POLYESTERS OF PHOSPHORIC-ACID .1. KINETICS AND THE PH PROFILE
    BARAN, J
    PENCZEK, S
    [J]. MACROMOLECULES, 1995, 28 (15) : 5167 - 5176
  • [2] Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles
    Chen, SC
    Jones, DH
    Fynan, EF
    Farrar, GH
    Clegg, JCS
    Greenberg, HB
    Herrmann, JE
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (07) : 5757 - 5761
  • [3] Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles
    Cohen, H
    Levy, RJ
    Gao, J
    Fishbein, I
    Kousaev, V
    Sosnowski, S
    Slomkowski, S
    Golomb, G
    [J]. GENE THERAPY, 2000, 7 (22) : 1896 - 1905
  • [4] Non-viral gene delivery systems
    Davis, ME
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 2002, 13 (02) : 128 - 131
  • [5] Garnett MC, 1999, CRIT REV THER DRUG, V16, P147
  • [6] Design and formulation of polyplexes based on pluronic-polyethyleneimine conjugates for gene transfer
    Gebhart, CL
    Sriadibhatla, S
    Vinogradov, S
    Lemieux, P
    Alakhov, V
    Kabanov, AV
    [J]. BIOCONJUGATE CHEMISTRY, 2002, 13 (05) : 937 - 944
  • [7] Antigen-specific induction of peripheral T cell tolerance in vivo by codelivery of DNA vectors encoding antigen and Fas ligand
    Georgantas, RW
    Leong, KW
    August, JT
    [J]. HUMAN GENE THERAPY, 2000, 11 (06) : 851 - 858
  • [8] In vitro and in vivo gene delivery mediated by a synthetic polycationic amino polymer
    Goldman, CK
    Soroceanu, L
    Smith, N
    Gillespie, GY
    Shaw, W
    Burgess, S
    Bilbao, G
    Curiel, DT
    [J]. NATURE BIOTECHNOLOGY, 1997, 15 (05) : 462 - 466
  • [9] Greene T. W., 1999, PROTECTIVE GROUPS OR
  • [10] Development of biomaterials for gene therapy
    Han, S
    Mahato, RI
    Sung, YK
    Kim, SW
    [J]. MOLECULAR THERAPY, 2000, 2 (04) : 302 - 317